Effect of Nicotinic Acid on Cardiovascular Risks Indices in Polycystic Ovary Syndrome
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
Niacin will improve postprandial hyperlipidaemia and cardiovascular risks indices via its
lipid lowering as well as via pleiotropic effects in patients with polycystic ovary syndrome
(PCOS).
Phase:
Phase 4
Details
Lead Sponsor:
Hull and East Yorkshire Hospitals NHS Trust Hull University Teaching Hospitals NHS Trust